Small Molecules
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,013
NCT05429177
A First-in-Human Study of QY101 Ointment in Adult Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 8, 2022
Completion: Jun 21, 2023
NCT05525715
A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis
Phase: Phase 1/2
Start: Oct 31, 2022
Completion: Dec 31, 2025
NCT05843422
A First-in-Human Study of QY211 Gel in Adult Subjects
Start: Mar 1, 2023
Completion: Oct 23, 2024
NCT06170840
A Study of QY101 Ointment in Subjects With Plaque Psoriasis
Phase: Phase 2
Start: May 17, 2023
Completion: Apr 30, 2024
NCT07180511
A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis.
Phase: Phase 3
Start: Mar 12, 2025
Completion: Jul 19, 2027
Loading map...